Staff Reporter : The Directorate General of Drug Administration (DGDA) suspended producing, sale, distribution and exporting all types of Ranitidine like medicines through issuing a public notice on Thursday.
Major General Md. Mahbubur Rahman, the Director General of DGDA signed the public notice in which it has been said that the raw materials and finished products of Ranitidine found not acceptable for human health.
In the notice it has been said that the level of NDMA Impurity in the finished medicine and in Ranitidine Hydrochloride, the raw materials of the medicine, imported from India’s M/S Saraka Laboratories and M/S Life science are found more than the acceptable level.
So the medicines are suspended, it added.
The samples of the medicine and its raw materials are examined in World Health Organisation accredited laboratories under the supervision of DGDA recently.
